In Qualcomm Inc. v. Apple Inc., the US Court of Appeals for the Federal Circuit reversed the Patent Trial and Appeal Board’s (PTAB) erroneous interpretation of 35 U.S.C. § 311(b), holding that... Read more »
In Cytiva BioProcess R&D AB v. JSR Corp. and JSR Life Sciences, LLC, the US Court of Appeals for the Federal Circuit found all claims challenged in six inter partes review (IPR)... Read more »